Arca
Skip to content

Desflurane

ANDA 208234, held by Shanghai Hengrui. Desflurane.

  • First approved: Feb 26, 2018
  • Review: Standard
  • Supplements approved: 2
  • Complete response letters: 0

Approvals and New Uses

The original application and every efficacy supplement, newest first; all 3 submissions below
DateSubmissionStatusDocuments
Feb 26, 2018Original applicationApprovedLetter

Products

1 strengths and forms
ProductActive ingredientMarketing
Desflurane100% · liquid;inhalationDesfluraneDiscontinued
All 3 submissions, including labeling and manufacturing supplements
DateSubmissionStatusDocuments
Nov 7, 2024Supplement 8Labeling · Standard reviewApprovedNone posted
Sep 30, 2019Supplement 4Labeling · Standard reviewApprovedNone posted
Feb 26, 2018Original applicationApprovedLetter

Identifiers

Application
ANDA 208234

Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed weekly; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.